الإحصائيات الأساسية
| LEI | 5493000EQUHM8VQXKW03 |
| CIK | 1855467 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Chavant Capital Acquisition Corp.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| September 4, 2025 |
Mobix Labs, Inc. Announces Exercise of Warrants for $4.5 Million Gross Proceeds Exhibit 99.1 Mobix Labs, Inc. Announces Exercise of Warrants for $4.5 Million Gross Proceeds IRVINE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Mobix Labs, Inc. (NASDAQ: MOBX), a fabless semiconductor company delivering advanced connectivity solutions for wired and wireless 5G, defense, aerospace, and medical applications today announced it has entered into an agreement with a holder of its existin |
|
| September 4, 2025 |
Exhibit 10.1 Mobix labs, inc. September 3, 2025 Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder: Mobix Labs, Inc. (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) the opportunity to receive new warrants to purchase shares of the Company’s Class A common stock, par value $0.00001 per share (the “ |
|
| September 4, 2025 |
COMMON STOCK PURCHASE WARRANT mobix labs, inc. Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| September 4, 2025 |
PROSPECTUS SUPPLEMENT NO. 3 MOBIX LABS, INC. Up to 15,373,309 SHARES OF CLASS A COMMON STOCK Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-287493 September 4, 2025 PROSPECTUS SUPPLEMENT NO. 3 MOBIX LABS, INC. Up to 15,373,309 SHARES OF CLASS A COMMON STOCK This prospectus supplement amends the prospectus dated August 11, 2025 (as supplemented to date, the “Prospectus”) of Mobix Labs, Inc. a Delaware corporation (the “Company”), which forms a part of the C |
|
| September 4, 2025 |
SECOND AMENDED AND RESTATED SERIES B COMMON STOCK PURCHASE WARRANT Mobix Labs, Inc. Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| September 4, 2025 |
COMMON STOCK PURCHASE WARRANT mobix labs, inc. Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| September 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 3, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File |
|
| September 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 13, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File |
|
| August 21, 2025 |
PROSPECTUS SUPPLEMENT NO. 2 MOBIX LABS, INC. Up to 15,373,309 SHARES OF CLASS A COMMON STOCK Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-287493 August 21, 2025 PROSPECTUS SUPPLEMENT NO. 2 MOBIX LABS, INC. Up to 15,373,309 SHARES OF CLASS A COMMON STOCK This prospectus supplement amends the prospectus dated August 11, 2025 (as supplemented to date, the “Prospectus”) of Mobix Labs, Inc. a Delaware corporation (the “Company”), which forms a part of the Com |
|
| August 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 13, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 15, 2025 |
PROSPECTUS SUPPLEMENT NO. 1 MOBIX LABS, INC. Up to 15,373,309 SHARES OF CLASS A COMMON STOCK Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-287493 August 15, 2025 PROSPECTUS SUPPLEMENT NO. 1 MOBIX LABS, INC. Up to 15,373,309 SHARES OF CLASS A COMMON STOCK This prospectus supplement amends the prospectus dated August 11, 2025 (the “Prospectus”) of Mobix Labs, Inc. a Delaware corporation (the “Company”), which forms a part of the Company’s Registration State |
|
| August 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 8, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40621 Mobix Labs, Inc. (Exact n |
|
| August 12, 2025 |
mobix labs, inc. UP TO 15,373,309 CLASS A COMMON STOCK PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-287493 mobix labs, inc. UP TO 15,373,309 CLASS A COMMON STOCK This prospectus relates to the registration of the resale or other distribution by the Selling Stockholders named herein of up to 15,373,309 shares of Class A common stock of Mobix Labs, Inc., par value $0.00001 per share (the “Class A Common Stock”) consisting of (a) up t |
|
| August 7, 2025 |
As filed with the Securities and Exchange Commission on August 6, 2025 As filed with the Securities and Exchange Commission on August 6, 2025 Registration No. |
|
| August 7, 2025 |
Exhibit 10.1 |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 23, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 7, 2025 |
Exhibit 10.46 |
|
| July 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 23, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Num |
|
| July 29, 2025 |
Press Release dated July 23, 2025 issued by the Company Exhibit 99.1 |
|
| July 2, 2025 |
Exhibit 99.1 Mobix Labs Launches Unsolicited Bid to Acquire Peraso in 20% Premium Deal to Shareholders—Accelerating Revenue Growth and Market Expansion Increasing revenue, combining scale, and realizing immediate synergies ~ ~ Creating a dominant force in high-growth mmWave and defense semiconductor markets ~ ~ Securing Nasdaq listing stability for Peraso shareholders ~` IRVINE, Calif. – June 26, |
|
| July 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 26, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Num |
|
| June 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 30, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) ( |
|
| June 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 30, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 22, 2025 |
Amended and Restated Form of Series B Common Warrant, dated April 7, 2025. Exhibit 4.8 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| May 22, 2025 |
As filed with the Securities and Exchange Commission on May 21, 2025 As filed with the Securities and Exchange Commission on May 21, 2025 Registration No. |
|
| May 22, 2025 |
Amended and Restated Form of Series A Common Warrant, dated April 7, 2025. Exhibit 4.7 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| May 22, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Mobix Labs, Inc. |
|
| May 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| May 15, 2025 |
Exhibit 10.7 MOBIX LABS, INC. amended and restated RESTRICTED STOCK AGREEMENT 1. Award of Restricted Stock. This Amended and Restated Restricted Stock Agreement (the “Amendment”) by and between Keyvan Samini (the “Recipient”) and Mobix Labs, Inc. (the “Company”) is effective May 5, 2025 (the “Effective Date”), and hereby supersedes and restates in its entirety that Restricted Stock Agreement (“Agr |
|
| May 15, 2025 |
Form of Amended and Restated Series B Common Stock Purchase Warrant. Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| May 15, 2025 |
Exhibit 10.6 MOBIX LABS, INC. AMENDED AND RESTATED RESTRICTED STOCK AGREEMENT 1. Award of Restricted Stock. This Amended and Restated Restricted Stock Agreement (the “Amendment”) by and between Fabrizio Battaglia (the “Recipient”) and Mobix Labs, Inc. (the “Company”) is effective May 5, 2025 (the “Effective Date”), and hereby supersedes and restates in its entirety that Restricted Stock Agreement |
|
| May 15, 2025 |
Form of Amended and Restated Series A Common Stock Purchase Warrant. Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| May 15, 2025 |
Exhibit 10.2 MOBIX LABS, INC. AMENDED AND RESTATED STOCK UNIT AGREEMENT THIS AMENDED AND RESTATED RSU AGREEMENT (“Amendment”) by and between Frederick Goerner (the “Participant”) and Mobix Labs, Inc. (the “Company”) is effective April 11, 2025 (the “Effective Date”), and hereby supersedes and restates in its entirety that RSU Agreement dated April 10, 2025 (the “Agreement”), and entered into by an |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40621 Mobix Labs, Inc. (Exact |
|
| May 15, 2025 |
Exhibit 10.1 MOBIX LABS, INC. SECOND AMENDED AND RESTATED RSU AGREEMENT THIS SECOND AMENDED AND RESTATED RSU AGREEMENT (“Second Amendment”) by and between James Peterson (the “Participant”) and Mobix Labs, Inc. (the “Company”) is effective April 11, 2025 (the “Effective Date”), and hereby supersedes and restates in its entirety that Amended and Restated RSU Agreement dated April 10, 2025 (the “Fir |
|
| May 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| May 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 28, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| April 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 10, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| April 7, 2025 |
Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| April 7, 2025 |
Exhibit 4.2 PRE-FUNDED COMMON STOCK PURCHASE WARRANT mobix labs, inc. Warrant Shares: Initial Exercise Date: April 7, 2025 Issue Date: April 7, 2025 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any tim |
|
| April 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 4, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Num |
|
| April 7, 2025 |
Exhibit 10.1 PLACEMENT AGENCY AGREEMENT April 4, 2025 Roth Capital Partners, LLC 888 San Clemente Drive, Suite 400 Newport Beach, CA 92660 Ladies and Gentlemen: Introduction. Subject to the terms and conditions herein (this “Agreement”), Mobix Labs, Inc., a Delaware corporation (the “Company”), hereby agrees to sell up to an aggregate of $3,999,990.30 of securities of the Company, including, but n |
|
| April 7, 2025 |
Exhibit 10.2 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of April 4, 2025, between Mobix Labs, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHEREAS, subject to the terms and conditions set for |
|
| April 7, 2025 |
PROSPECTUS SUPPLEMENT (To the Prospectus dated January 24, 2025) Filed Pursuant to Rule 424(b)(5) Registration No. |
|
| April 7, 2025 |
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| April 7, 2025 |
MOBIX LABS ANNOUNCES $4.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES Exhibit 99.1 MOBIX LABS ANNOUNCES $4.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES IRVINE, Calif / BUSINESS WIRE / April 4, 2025 / Mobix Labs, Inc. (Nasdaq: MOBX, “Mobix Labs” or the “Company”), a leading provider of advanced connectivity solutions, today announced that it has entered into a definitive agreement with institutional investors for the purchase and sale |
|
| March 28, 2025 |
Exhibit 99.4 MOBIX LABS, INC. RESTRICTED STOCK UNIT AGREEMENT 1. Award of Restricted Stock Units. Pursuant to the terms and conditions of this Restricted Stock Unit Agreement effective (the “Agreement”) and in accordance with the approval granted by the shareholders of the Company at its Special Meeting of Shareholders held January 3, 2025, MOBIX LABS, INC., a Delaware corporation (the “Company”) |
|
| March 28, 2025 |
Exhibit 99.5 MOBIX LABS, INC. RESTRICTED STOCK UNIT AGREEMENT 1. Award of Restricted Stock Units. Pursuant to the terms and conditions of this Restricted Stock Unit Agreement effective (the “Agreement”) and in accordance with the approval granted by the shareholders of the Company at its Special Meeting of Shareholders held January 3, 2025, MOBIX LABS, INC., a Delaware corporation (the “Company”) |
|
| March 28, 2025 |
Exhibit 99.3 MOBIX LABS, INC. RESTRICTED STOCK UNIT AGREEMENT 1. Award of Restricted Stock Units. Pursuant to the terms and conditions of this Restricted Stock Unit Agreement effective (the “Agreement”) and in accordance with the approval granted by the shareholders of the Company at its Special Meeting of Shareholders held January 3, 2025, MOBIX LABS, INC., a Delaware corporation (the “Company”) |
|
| March 28, 2025 |
As filed with the Securities and Exchange Commission on March 27, 2025. As filed with the Securities and Exchange Commission on March 27, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 3674 98-1591717 (State or other jurisdiction of Incorporation or organization) (Primary |
|
| March 28, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Mobix Labs, Inc. |
|
| March 28, 2025 |
Restricted Stock Unit Award Agreement by and between Mobix Labs, Inc. and James Peterson. Exhibit 99.1 MOBIX LABS, INC. RESTRICTED STOCK UNIT AGREEMENT 1. Award of Restricted Stock Units. Pursuant to the terms and conditions of this Restricted Stock Unit Agreement effective (the “Agreement”) and in accordance with the approval granted by the shareholders of the Company at its Special Meeting of Shareholders held January 3, 2025, MOBIX LABS, INC., a Delaware corporation (the “Company”) |
|
| March 28, 2025 |
Exhibit 99.11 MOBIX LABS, INC. 2023 EQUITY INCENTIVE PLAN (AS AMENDED) MOBIX LABS, INC. 2023 EQUITY INCENTIVE PLAN 1. Purpose 1 2. Definitions 1 3. Administration 5 4. Shares Subject to Plan 6 5. Eligibility 7 6. Specific Terms of Awards 7 7. Certain Provisions Applicable to Awards 13 8. Change in Control 15 9. General Provisions 16 MOBIX LABS, INC. 2023 EQUITY INCENTIVE PLAN 1. Purpose. The purpo |
|
| March 28, 2025 |
Restricted Stock Award Agreement by and between Mobix Labs, Inc. and Fabian Battaglia. Exhibit 99.6 MOBIX LABS, INC. RESTRICTED STOCK AGREEMENT` 1. Award of Restricted Stock. Pursuant to the terms and conditions of this Restricted Stock Agreement (“Agreement”) effective , 2025 (the “Effective Date”) and in accordance with the approval granted by the shareholders of Mobix Labs, Inc. (the “Company”) at its Special Meeting of Shareholders held January 3, 2025, the Company hereby grants |
|
| March 28, 2025 |
Restricted Stock Award Agreement by and between Mobix Labs, Inc. and Keyvan Samini. Exhibit 99.7 MOBIX LABS, INC. RESTRICTED STOCK AGREEMENT` 1. Award of Restricted Stock. Pursuant to the terms and conditions of this Restricted Stock Agreement (“Agreement”) effective , 2025 (the “Effective Date”) and in accordance with the approval granted by the shareholders of Mobix Labs, Inc. (the “Company”) at its Special Meeting of Shareholders held January 3, 2025, the Company hereby grants |
|
| March 28, 2025 |
Restricted Stock Unit Award Agreement by and between Mobix Labs, Inc. and Kristen Schmidt. Exhibit 99.8 MOBIX LABS, INC. RESTRICTED STOCK UNIT AGREEMENT 1. Award of Restricted Stock Units. Pursuant to the terms and conditions of this Restricted Stock Unit Agreement effective (the “Agreement”) and in accordance with the approval granted by the shareholders of the Company at its Special Meeting of Shareholders held January 3, 2025, MOBIX LABS, INC., a Delaware corporation (the “Company”) |
|
| March 28, 2025 |
Restricted Stock Unit Award Agreement by and between Mobix Labs, Inc. and Christopher Lancaster. Exhibit 99.10 MOBIX LABS, INC. RESTRICTED STOCK UNIT AGREEMENT 1. Award of Restricted Stock Units. Pursuant to the terms and conditions of this Restricted Stock Unit Agreement effective (the “Agreement”) and in accordance with the approval granted by the shareholders of the Company at its Special Meeting of Shareholders held January 3, 2025, MOBIX LABS, INC., a Delaware corporation (the “Company”) |
|
| March 28, 2025 |
Restricted Stock Unit Award Agreement by and between Mobix Labs, Inc. and Frederick Goerner. Exhibit 99.2 MOBIX LABS, INC. RESTRICTED STOCK UNIT AGREEMENT 1. Award of Restricted Stock Units. Pursuant to the terms and conditions of this Restricted Stock Unit Agreement effective (the “Agreement”) and in accordance with the approval granted by the shareholders of the Company at its Special Meeting of Shareholders held January 3, 2025, MOBIX LABS, INC., a Delaware corporation (the “Company”) |
|
| March 28, 2025 |
Restricted Stock Unit Award Agreement by and between Mobix Labs, Inc. and Nanette Young. Exhibit 99.9 MOBIX LABS, INC. RESTRICTED STOCK UNIT AGREEMENT 1. Award of Restricted Stock Units. Pursuant to the terms and conditions of this Restricted Stock Unit Agreement effective (the “Agreement”) and in accordance with the approval granted by the shareholders of the Company at its Special Meeting of Shareholders held January 3, 2025, MOBIX LABS, INC., a Delaware corporation (the “Company”) |
|
| March 7, 2025 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 3, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Num |
|
| February 21, 2025 |
~ Revenue Growth and Margin Expansion Highlight a Strong Start to the Year ~ Exhibit 99.1 Mobix Labs, Inc. Announces First Quarter 2025 Financial Results February 18, 2025 ~ Revenue Growth and Margin Expansion Highlight a Strong Start to the Year ~ IRVINE, Calif.—(BUSINESS WIRE)—Feb. 18, 2025— Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs” or the “Company”), a leading provider of advanced connectivity solutions, today announced financial results for the first quarter of fis |
|
| February 21, 2025 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 18, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File |
|
| February 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40621 Mobix Labs, Inc. (Exa |
|
| January 28, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 22, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File |
|
| January 28, 2025 |
EXHIBIT 99.1 Mobix Labs Powers Into Aerospace and Defense with Acquisition of SCP Manufacturing ~Second Strategic Acquisition in 60 Days Positions Mobix Labs as a Market Leader ~ Irvine, Calif., January 22, 2025 – Mobix Labs, Inc. (Nasdaq: MOBX), a global leader in advanced connectivity solutions, has unveiled another game-changing move with its acquisition of SCP Manufacturing, a Nevada-based pro |
|
| January 22, 2025 |
Mobix Labs, Inc. 15420 Laguna Canyon Road, Suite 100 Irvine, California 92618 Mobix Labs, Inc. 15420 Laguna Canyon Road, Suite 100 Irvine, California 92618 January 22, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3561 Attention: Jenny O’Shanick Re: Mobix Labs, Inc. Registration Statement on Form S-3 Filed January 17, 2025 File No. 333-284351 Dear Ms. O’Shanick: Mobix Labs, Inc. (the |
|
| January 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of |
|
| January 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| January 17, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Mobix Labs, Inc. |
|
| January 17, 2025 |
Form of Indenture relating to the Senior Debt Securities. Exhibit 4.9 MOBIX LABS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20[●] Senior Debt Securities INDENTURE INDENTURE, dated as of [●], 20[●], among MOBIX LABS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”): WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide |
|
| January 17, 2025 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 17, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File |
|
| January 17, 2025 |
Form of Indenture relating to the Subordinated Debt Securities. Exhibit 4.10 MOBIX LABS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20[●] Subordinated Debt Securities Table of Contents1 Article 1. DEFINITIONS 1 Section 1.01 Definitions of Terms. 1 Article 2. ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 5 Section 2.01 Designation and Terms of Securities. 5 Section 2.02 Form of Securities and Trustee’s Certifi |
|
| January 17, 2025 |
As filed with the Securities and Exchange Commission on January 17, 2025 As filed with the Securities and Exchange Commission on January 17, 2025 Registration Statement No. |
|
| January 17, 2025 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On December 21, 2023, the parties consummated the merger pursuant to the business combination agreement, dated November 15, 2022 (as amended, supplemented or otherwise modified, the “Business Combination Agreement”), by and among Chavant Capital Acquisition Corp. (“Chavant”), CLAY Merger Sub II, Inc., a Delaware corporation |
|
| January 13, 2025 |
Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-278710 January 10, 2025 PROSPECTUS SUPPLEMENT NO. 5 MOBIX LABS, INC. 19,905,953 SHARES OF CLASS A COMMON STOCK 3,000,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,000,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement amends the prospectus dated July 2, 2024 (as supplemented t |
|
| January 13, 2025 |
PROSPECTUS SUPPLEMENT NO. 2 MOBIX LABS, INC. UP TO 8,834,533 SHARES OF CLASS A COMMON STOCK Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-281492 January 10, 2025 PROSPECTUS SUPPLEMENT NO. 2 MOBIX LABS, INC. UP TO 8,834,533 SHARES OF CLASS A COMMON STOCK This prospectus supplement amends the prospectus dated August 29, 2024 (as supplemented to date, the “Prospectus”) of Mobix Labs, Inc. a Delaware corporation (the “Company”), which forms a part of the Com |
|
| January 6, 2025 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 3, 2025 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File N |
|
| December 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40621 MOBIX LABS, INC. (Exact |
|
| December 26, 2024 |
Mobix Labs, Inc.’s Insider Trading Policy Exhibit 19.1 |
|
| December 26, 2024 |
Exhibit 4.9 DESCRIPTION OF SECURITIES The following summary of the material terms of our securities is not intended to be a complete summary of the rights and preferences of such securities. The full text of our Charter and amendment to the Charter, which together are referred to as the Charter, and Bylaws is included as Exhibit 3.1, Exhibit 3.2, and Exhibit 3.3 respectively, in the Annual Report |
|
| December 20, 2024 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 19, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File |
|
| December 20, 2024 |
Exhibit 99.1 Mobix Labs, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results Revenue up 44% sequentially and significant Gross Margin expansion Acquisition strategy successfully expanding end markets and diversifying offerings Increasing Customer Demand IRVINE, Calif.– December 19, 2024 – Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs”, “Mobix” or the “Company”), a leader in advanced |
|
| December 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| December 2, 2024 |
Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-278710 November 29, 2024 PROSPECTUS SUPPLEMENT NO. 3 MOBIX LABS, INC. 19,905,953 SHARES OF CLASS A COMMON STOCK 3,000,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,000,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement amends the prospectus dated July 2, 2024 (as supplemented |
|
| December 2, 2024 |
PROSPECTUS SUPPLEMENT NO. 1 MOBIX LABS, INC. UP TO 8,834,533 SHARES OF CLASS A COMMON STOCK Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-281492 November 29, 2024 PROSPECTUS SUPPLEMENT NO. 1 MOBIX LABS, INC. UP TO 8,834,533 SHARES OF CLASS A COMMON STOCK This prospectus supplement amends the prospectus dated August 29, 2024 (as supplemented to date, the “Prospectus”) of Mobix Labs, Inc. a Delaware corporation (the “Company”), which forms a part of the Co |
|
| November 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| November 29, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 25, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File |
|
| November 29, 2024 |
Exhibit 99.1 Mobix Labs Announces Strategic Acquisition of Spacecraft Components ~ Strategic move expanding Mobix Labs’ reach in aerospace, defense, and transportation ~ ~ Acquisition expected to increase Revenue and Earnings on Close ~ IRVINE, Calif.—(BUSINESS WIRE)—Nov. 25, 2024— Mobix Labs, Inc. (Nasdaq: MOBX), a global innovator in advanced connectivity solutions, today announced it has agreed |
|
| November 22, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 18, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File |
|
| November 14, 2024 |
MOBX / Mobix Labs, Inc. / ARMISTICE CAPITAL, LLC Passive Investment SC 13G 1 armistice-mobx093024.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MOBIX LABS, INC. (Name of Issuer) Class A Common Stock, par value $0.00001 per share (Title of Class of Securities) 60743G100 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check t |
|
| October 21, 2024 |
Exhibit 99.2 Mobix Labs’ Board Members Jimmy Peterson and David Aldrich Praise Company’s Success and Growth in 2024 Following Microsemi Playbook Leads to 426% Revenue Increase Over Prior Fiscal Year IRVINE, Calif., Oct. 17, 2024 — Mobix Labs Inc. (Nasdaq: MOBX) (“Mobix Labs”), a leader in advanced connectivity solutions for defense, military and communications applications, led by such industry bo |
|
| October 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 15, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File |
|
| October 21, 2024 |
Exhibit 99.1 Mobix Labs Achieves 44% Sequential Revenue Growth in Fiscal Q’4 2024 Annual revenue of more than $6.4 million increases 426% compared to fiscal 2023 Acquisition strategy continues to fuel increasing customer demand IRVINE, Calif., October 15, 2024 — Mobix Labs Inc. (Nasdaq: MOBX) (“Mobix Labs”), a leader in advanced connectivity solutions, today announced selected preliminary results |
|
| September 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (a |
|
| September 30, 2024 |
Exhibit 99.1 Mobix Labs Submits All Cash Offer to Acquire EMCORE Corporation Synergistic Acquisition would enhance Mobix Labs’ competitive strength in aerospace and defense sector Scales operations and cash flow IRVINE, Calif.-(BUSINESS WIRE)-Sep. 30, 2024- Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs”, “Mobix” or the “Company”), a leader in advanced wireless and connectivity solutions for the mil |
|
| September 30, 2024 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 30, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 29, 2024 |
mobix labs, inc. UP TO 8,834,533 SHARES OF CLASS A COMMON STOCK PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-281492 mobix labs, inc. UP TO 8,834,533 SHARES OF CLASS A COMMON STOCK Pursuant to this prospectus, the selling stockholders identified herein (the “Selling Stockholders”) are offering on a resale basis an aggregate of up to 8,834,533 shares of Class A common stock of Mobix Labs, Inc., par value $0.00001 per share (the “Class A Commo |
|
| August 26, 2024 |
As filed with the Securities and Exchange Commission on August 26, 2024 As filed with the Securities and Exchange Commission on August 26, 2024 No. 333-281492 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 3674 98-1591717 (State or other jurisdiction of Incorporation or organizatio |
|
| August 26, 2024 |
Mobix Labs, Inc. 15420 Laguna Canyon Rd., Suite 100 Irvine, California 92618 Mobix Labs, Inc. 15420 Laguna Canyon Rd., Suite 100 Irvine, California 92618 August 26, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3561 Attention: Eranga Dias Re: Mobix Labs, Inc. Amendment No. 1 to the Registration Statement on Form S-1 Filed August 26, 2024 File No. 333-281492 Dear Mr. Dias: Mobix Labs |
|
| August 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 21, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File N |
|
| August 21, 2024 |
Exhibit 99.1 Mobix Labs Announces Third Quarter 2024 Financial Results Revenue up 80% sequentially and Gross Margin expansion Acquisition strategy successfully expanding end markets and diversifying offerings Increasing Customer Demand IRVINE, Calif.– August 21, 2024 – Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs”, “Mobix” or the “Company”), a leader in advanced connectivity solutions, today annou |
|
| August 14, 2024 |
PROSPECTUS SUPPLEMENT NO. 4 MOBIX LABS, INC. 9,500,000 SHARES OF CLASS A COMMON STOCK Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-278451 August 14, 2024 PROSPECTUS SUPPLEMENT NO. 4 MOBIX LABS, INC. 9,500,000 SHARES OF CLASS A COMMON STOCK This prospectus supplement amends the prospectus dated May 13, 2024 (as supplemented to date, the “Prospectus”) of Mobix Labs, Inc. a Delaware corporation (the “Company”), which forms a part of the Company’s Reg |
|
| August 14, 2024 |
Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-278451 August 14, 2024 PROSPECTUS SUPPLEMENT NO. 2 MOBIX LABS, INC. 19,905,953 SHARES OF CLASS A COMMON STOCK 3,000,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,000,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement amends the prospectus dated July 2, 2024 (as supplemented to |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40621 Mobix Labs, Inc. (Exact n |
|
| August 12, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Mobix Labs, Inc. |
|
| August 12, 2024 |
As filed with the Securities and Exchange Commission on August 12, 2024 As filed with the Securities and Exchange Commission on August 12, 2024 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 3674 98-1591717 (State or other jurisdiction of Incorporation or organization) (Primary Standard Indu |
|
| July 25, 2024 |
PROSPECTUS SUPPLEMENT NO. 3 MOBIX LABS, INC. 9,500,000 SHARES OF CLASS A COMMON STOCK Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-278451 July 24, 2024 PROSPECTUS SUPPLEMENT NO. 3 MOBIX LABS, INC. 9,500,000 SHARES OF CLASS A COMMON STOCK This prospectus supplement amends the prospectus dated May 13, 2024 (as supplemented to date, the “Prospectus”) of Mobix Labs, Inc. a Delaware corporation (the “Company”), which forms a part of the Company’s Regis |
|
| July 25, 2024 |
Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-278451 July 24, 2024 PROSPECTUS SUPPLEMENT NO. 1 MOBIX LABS, INC. 19,905,953 SHARES OF CLASS A COMMON STOCK 3,000,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,000,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus supplement amends the prospectus dated July 2, 2024 (as supplemented to d |
|
| July 24, 2024 |
Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| July 24, 2024 |
Mobix Labs Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules Exhibit 99.1 Mobix Labs Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules IRVINE, Calif.— July 23, 2024, Mobix Labs Inc. (Nasdaq: MOBX), a leader in advanced connectivity solutions, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 2,877,698 shares of its Class A common stock (or Class A common stock equivalents |
|
| July 24, 2024 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of July 22, 2024, by and between Mobix Labs, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). This Agreement is made pursuant to the Securities Purchase |
|
| July 24, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of July 22, 2024, between Mobix Labs, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHEREAS, subject to the terms and conditions set for |
|
| July 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 22, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Num |
|
| July 24, 2024 |
Exhibit 10.3 LOCK-UP AGREEMENT July 22, 2024 Re: Securities Purchase Agreement, dated as of July 22, 2024 (the “Purchase Agreement”), between Mobix Labs Inc. (the “Company”) and the purchasers signatory thereto (each, a “Purchaser” and, collectively, the “Purchasers”) Ladies and Gentlemen: Defined terms not otherwise defined in this letter agreement (the “Letter Agreement”) shall have the meanings |
|
| July 24, 2024 |
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| July 24, 2024 |
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| July 24, 2024 |
Exhibit 4.4 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| July 3, 2024 |
PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-278710 mobix labs, inc. 19,905,953 SHARES OF CLASS A COMMON STOCK 3,000,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK 6,000,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS This prospectus relates to the offer and sale from time to time by the selling securityholders named in this prospectus (the “Selling Securityhold |
|
| June 28, 2024 |
June 28, 2024 VIA EDGAR Office of Manufacturing Division of Corporation Finance Securities and Exchange Commission 100 F Street NE Washington, D. |
|
| June 28, 2024 |
Mobix Labs, Inc. 15420 Laguna Canyon Rd., Suite 100 Irvine, California 92618 Mobix Labs, Inc. 15420 Laguna Canyon Rd., Suite 100 Irvine, California 92618 June 28, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3561 Attention: Thomas Jones Erin Purnell Re: Mobix Labs, Inc. Amendment No. 1 to the Registration Statement on Form S-1 Filed June 6, 2024 File No. 333-278710 Dear Mr. Jones a |
|
| June 11, 2024 |
Exhibit 99.1 Mobix Labs Announces Mid-Quarter Business Update Projects revenue increase of more than 70% sequential growth to more than $2 million Successful execution of second acquisition in five months IRVINE, Calif.-(BUSINESS WIRE)-Today, Mobix Labs Inc. (Nasdaq: MOBX), a leader in advanced connectivity solutions, today announced a mid-quarter business update. Keyvan Samini, President and CFO |
|
| June 11, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 10, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Num |
|
| June 6, 2024 |
As filed with the Securities and Exchange Commission on June 5, 2024 As filed with the Securities and Exchange Commission on June 5, 2024 No. 333-278710 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 3674 98-1591717 (State or other jurisdiction of Incorporation or organization) |
|
| June 5, 2024 |
June 5, 2024 VIA EDGAR Office of Manufacturing Division of Corporation Finance Securities and Exchange Commission 100 F Street NE Washington, D. |
|
| May 23, 2024 |
PROSPECTUS SUPPLEMENT NO. 2 mobix labs, inc. 9,500,000 SHARES OF CLASS A COMMON STOCK Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-278451 May 23, 2024 PROSPECTUS SUPPLEMENT NO. 2 mobix labs, inc. 9,500,000 SHARES OF CLASS A COMMON STOCK This prospectus supplement amends the prospectus (the “Initial Prospectus”) dated May 13, 2024 (as supplemented to date, the “Prospectus”) of Mobix Labs, Inc. a Delaware corporation (the “Company”), which forms a p |
|
| May 23, 2024 |
Unregistered Sales of Equity Securities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 21, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 17, 2024 |
PROSPECTUS SUPPLEMENT NO. 1 MOBIX LABS, INC. 9,500,000 SHARES OF CLASS A COMMON STOCK Filed Pursuant to Rule 424(b)(3) and Rule 424(c) Registration Statement No. 333-278451 May 16, 2024 PROSPECTUS SUPPLEMENT NO. 1 MOBIX LABS, INC. 9,500,000 SHARES OF CLASS A COMMON STOCK This prospectus supplement amends the prospectus dated May 13, 2024 (as supplemented to date, the “Prospectus”) of Mobix Labs, Inc. a Delaware corporation (the “Company”), which forms a part of the Company’s Regist |
|
| May 16, 2024 |
mobix labs, inc. 9,500,000 SHARES OF CLASS A COMMON STOCK PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-278451 mobix labs, inc. 9,500,000 SHARES OF CLASS A COMMON STOCK This prospectus relates to the offer and sale of up to 9,500,000 shares, or the Purchase Shares, of our Class A common stock, par value $0.00001 per share, or Class A Common Stock, by B. Riley Principal Capital II, LLC, whom we refer to in this prospectus as “B. Riley P |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40621 Mobix Labs, Inc. (Exact |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 14, 2024 |
Exhibit 99.1 Mobix Labs, Inc. Announces Second Quarter 2024 Financial Results Quarterly Revenue up more than 300% sequentially Successfully signed definitive agreement to acquire RaGE Systems Acquisition strategy successfully expanding end markets and diversifying offerings IRVINE, Calif.-(BUSINESS WIRE)- Mobix Labs, Inc. (Nasdaq: MOBX) (“Mobix Labs” or the “Company”), a fabless semiconductor comp |
|
| May 14, 2024 |
Exhibit 99.1 Execution Copy BUSINESS COMBINATION AGREEMENT by and among Mobix Labs, Inc., Mobix Merger Sub III, LLC and RaGE Systems, Inc. Dated as of May 8, 2024 Article I. DEFINITIONS 2 Section 1.01 Certain Definitions 2 Section 1.02 Further Definitions 10 Section 1.03 Construction 12 Article II. transactions 12 Section 2.01 The Merger 12 Section 2.02 Effective Time; Closing 12 Section 2.03 Effe |
|
| May 14, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 14, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 10, 2024 |
Exhibit 99.1 Mobix Labs Announces Strategic Acquisition of RaGE Systems May 9, 2024 -Acquisition to immediately increase Mobix Labs Revenue and Earnings – Synergies will accelerate breakthrough advancements for wireless communications IRVINE, Calif.-(BUSINESS WIRE)-May 9, 2024- Mobix Labs, Inc. (Nasdaq: MOBX), a fabless semiconductor company known for its innovative connectivity solutions, today a |
|
| May 10, 2024 |
Mobix Labs, Inc. 15420 Laguna Canyon Rd., Suite 100 Irvine, California 92618 Mobix Labs, Inc. 15420 Laguna Canyon Rd., Suite 100 Irvine, California 92618 May 10, 2024 Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, DC 20549 Attention: Mr. Thomas Jones and Ms. Erin Purnell Re: Mobix Labs, Inc. Registration Statement on Form S-1 File No. 333-278451 Dear Mr. Jones and Ms. Purnell: Mobix Labs, Inc. (the “Company”) hereby requests a |
|
| May 2, 2024 |
As filed with the Securities and Exchange Commission on May 1, 2024 As filed with the Securities and Exchange Commission on May 1, 2024 No. 333-278451 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 3674 98-1591717 (State or other jurisdiction of Incorporation or organization) ( |
|
| May 1, 2024 |
May 1, 2024 VIA EDGAR Office of Manufacturing Division of Corporation Finance Securities and Exchange Commission 100 F Street NE Washington, D. |
|
| April 29, 2024 |
MOBX / Mobix Labs, Inc. / Ma Jiong - AMENDMENT NO. 1 TO SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Mobix Labs, Inc. (Name of Issuer) Class A Common Stock, par value $0.00001 per share (Title of Class of Securities) 60743G 100 (CUSIP Number) Jiong Ma 445 Park Avenue, 9th Floor New York, New York, 10022 (Name, Address and Telephone Number of Person Aut |
|
| April 16, 2024 |
As filed with the Securities and Exchange Commission on April 15, 2024 As filed with the Securities and Exchange Commission on April 15, 2024 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 3674 98-1591717 (State or other jurisdiction of Incorporation or organization) (Primary Standard Indus |
|
| April 16, 2024 |
As filed with the Securities and Exchange Commission on April 15, 2024. As filed with the Securities and Exchange Commission on April 15, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 3674 98-1591717 (State or other jurisdiction of Incorporation or organization) (Primary |
|
| April 16, 2024 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-8 (Form Type) MOBIX LABS, INC. |
|
| April 16, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Mobix Labs, Inc. |
|
| April 2, 2024 |
As filed with the Securities and Exchange Commission on April 1, 2024 As filed with the Securities and Exchange Commission on April 1, 2024 No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 3674 98-1591717 (State or other jurisdiction of Incorporation or organization) (Primary Standard Indust |
|
| April 2, 2024 |
Exhibit 3.2 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION OF CHAVANT CAPITAL ACQUISITION CORP. Chavant Capital Acquisition Corp., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify as follows: 1. The certificate of incorporation of the corporation is hereby amended by deleting the text of Article FIRST th |
|
| April 2, 2024 |
Exhibit 2.4 AMENDMENT NO. 3 TO THE BUSINESS COMBINATION AGREEMENT This AMENDMENT NO. 3 (this “Amendment”), dated as of February 12th, 2024, to the Business Combination Agreement, dated as of November 15, 2022 as amended on April 5, 2023 and November 26, 2023 (as so amended, the “Current Agreement”), is by and among Mobix Labs, Inc., a Delaware corporation (f/k/a Chavant Capital Acquisition Corp.) |
|
| April 2, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Mobix Labs, Inc. |
|
| March 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 18, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| March 19, 2024 |
Exhibit 99.1 Mobix Labs Secures $100 Million Committed Equity Facility Capital Enhances Financial Flexibility for Future Growth and M&A Strategy IRVINE, Calif., Mar. 19, 2023— Mobix Labs Inc. (Nasdaq: MOBX) (“Mobix Labs”), a fabless semiconductor company developing disruptive next-generation connectivity solutions that span from wired to next-generation wireless solutions, including 5G, today anno |
|
| March 19, 2024 |
Exhibit 10.2 Execution Version REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 18, 2024, is by and between B. Riley Principal Capital II, LLC, a Delaware limited liability company (the “Investor”), and Mobix Labs, Inc., a Delaware corporation (the “Company”). RECITALS A. The Company and the Investor have entered into that certain Common Stock |
|
| March 19, 2024 |
Exhibit 10.1 Execution Version COMMON STOCK PURCHASE AGREEMENT Dated as of March 18, 2024 by and between MOBIX LABS, INC. and B. RILEY PRINCIPAL CAPITAL II, LLC Table of Contents Page Article I DEFINITIONS 1 Article II PURCHASE AND SALE OF COMMON STOCK 2 Section 2.1. Purchase and Sale of Stock 2 Section 2.2. Closing Date; Settlement Dates 2 Section 2.3. Initial Public Announcements and Required Fi |
|
| March 12, 2024 |
Exhibit 99.1 Mobix Labs Announces Mid-Quarter Business Update -Mobix Labs projects greater than 250% revenue growth over prior quarter- -Expanding customer base and successful implementation of its merger and acquisition strategy- IRVINE, Calif. – (BUSINESS WIRE) – Mar. 11, 2024 – Mobix Labs, Inc. (Nasdaq: MOBX), a fabless semiconductor company developing disruptive next-generation connectivity so |
|
| March 12, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 11, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| February 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40621 Mobix Labs, Inc. (Exact nam |
|
| February 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report o |
|
| January 24, 2024 |
Filed Pursuant to Rule 424(b)(3) Registration Nos. 333-271197 and 333-275818 PROSPECTUS SUPPLEMENT NO. 3 (to Proxy Statement/Prospectus dated November 13, 2023) MOBIX LABS, INC. PROSPECTUS FOR 6,000,000 SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK OF MOBIX LABS, INC. This Prospectus Supplement No. 3 (“Supplement No. 3”) is being filed to update and |
|
| January 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 22, 2024 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File |
|
| January 23, 2024 |
Exhibit 99.1 Dear Warrant holder, Reference is hereby made to that certain Warrant Agreement (the “Existing Warrant Agreement”), dated July 19, 2021, by and among Chavant Capital Acquisition Corp. (the “Company”) and Continental Stock Transfer & Trust Company (“CST”), as modified by that certain Amendment to Warrant Agreement (“Amendment” and the Existing Warrant Agreement, as modified by the Amen |
|
| January 23, 2024 |
PIPE Warrant, dated December 19, 2023, by and among the Company and Mr. Michael Long. Exhibit 10.2 Execution Version NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY TH |
|
| January 23, 2024 |
Subscription Agreement, dated December 19, 2023, by and among the Company and Mr. Michael Long. Exhibit 10.1 Execution Copy SUBSCRIPTION AGREEMENT Chavant Capital Acquisition Corp. 445 Park Avenue, 9th Floor New York, NY 10022 Ladies and Gentlemen: In connection with the proposed business combination (the “Transaction”) between Chavant Capital Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands (together with any successor thereto, including af |
|
| January 2, 2024 |
MOBX / Mobix Labs, Inc. / Sage Hill Investors, LLC - SC 13G Passive Investment SC 13G 1 tm2333981d4sc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Mobix Labs, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 60743G 100 (CUSIP Number) December 21, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu |
|
| January 2, 2024 |
MOBX / Mobix Labs, Inc. / Peterson James J - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) Mobix Labs, Inc. (Name of Issuer) Common stock, par value $0.00001 per share (Title of Class of Securities) 60743G 100 (CUSIP Number) Keyvan Samini Chief Financial Officer Mobix Labs, Inc. 15420 Laguna Canyon Rd., Suite 100 Irvine, California 92618 (949) 7 |
|
| January 2, 2024 |
EX-99.1 2 tm2333981d4ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 JOINT FILING AGREEMENT In accordance with the requirements of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and subject to the limitations set forth therein, the parties set forth below agree to jointly file the Schedule 13G to which this Joint Filing Agreement is attached and have duly executed this Joint Filing Agre |
|
| January 2, 2024 |
MOBX / Mobix Labs, Inc. / Chavant Capital Partners LLC - SC 13D Activist Investment SC 13D 1 tm2333981d2sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Mobix Labs, Inc. (Name of Issuer) Class A Common Stock, par value $0.00001 per share (Title of Class of Securities) 60743G 100 (CUSIP Number) Jiong Ma 445 Park Avenue, 9th Floor New York, New York, 10022 (Name, Address |
|
| December 28, 2023 |
Exhibit 10.3 Execution Version INDEMNIFICATION And Advancement AGREEMENT This Indemnification and Advancement Agreement (as amended or amended and restated, this “Agreement”) is made as of December 21, 2023 (the “Effective Date”) by and between Mobix Labs, Inc. (the “Company”), and [ ● ], [ ● ] of the Company (“Indemnitee”). WITNESSETH THAT: WHEREAS, the Board of Directors of the Company (the “Boa |
|
| December 28, 2023 |
Exhibit 3.2 BYLAWS OF MOBIX LABS, INC. ARTICLE I Meetings of Stockholders Section 1.1 Annual Meetings. If required by applicable law, an annual meeting of stockholders shall be held for the election of directors at such date, time and place, if any, either within or without the State of Delaware, as may be designated by resolution or resolutions of the Board of Directors (the “Boa |
|
| December 28, 2023 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Capitalized terms included below but not defined in this Exhibit 99.3 shall have the same meanings ascribed to them in the Current Report on Form 8-K (the “Form 8-K”) filed with the Securities and Exchange Commission (the “SEC”) on December 28, 2023 and, if not defined in the Form 8-K, the final prospectus and definitive pro |
|
| December 28, 2023 |
EMI SOLUTIONS, INC. Unaudited Condensed Interim Financial Statements Exhibit 99.4 EMI SOLUTIONS, INC. Unaudited Condensed Interim Financial Statements Page Condensed Balance Sheets as of September 30, 2023 and June 30, 2023 (unaudited) 2 Condensed Statements of Operations and Comprehensive Income (Loss) for the three months ended September 30, 2023 and September 30, 2022 (unaudited) 3 Condensed Statements of Shareholders’ Equity for the three months ended September |
|
| December 28, 2023 |
Exhibit 99.1 Risk Factors Unless otherwise indicated or the context otherwise requires, all references in this Exhibit 99.1 shall have the meanings ascribed to them in the Current Report on Form 8-K (the “Form 8-K”) filed with the Securities and Exchange Commission (the “SEC”) on December 28, 2023 and, if not defined in the Form 8-K, the final prospectus and definitive proxy statement dated Novemb |
|
| December 28, 2023 |
Exhibit 2.4 Execution Copy Agreement and Plan of Merger by and among Mobix Labs, Inc., Mobix Merger Sub I, Inc., Mobix Merger Sub II, LLC, EMI Solutions, Inc., the Shareholder named herein and the Owners named herein Dated as of September 26, 2022 Table of Contents Page Article I the mergerS 2 Section 1.1. The Mergers 2 Section 1.2. Closing 2 Section 1.3. Effective Times 2 Section 1.4. Effects of |
|
| December 28, 2023 |
Exhibit 10.2 Execution Version AMENDED AND RESTATED REGISTRATION RIGHTS AND LOCK-UP AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AND LOCK-UP AGREEMENT (this “Agreement”), dated as of December 21, 2023, is made and entered into by and among Mobix Labs, Inc., a Delaware corporation f/k/a Chavant Capital Acquisition Corp., (the “Company”), Chavant Capital Partners LLC, a Delaware limited l |
|
| December 28, 2023 |
Report of Independent Registered Public Accounting Firm Exhibit 99. 2 Mobix Labs Operations, Inc. (formerly known as Mobix Labs, Inc.) Audited Financial Statements Years Ended September 30, 2023 and 2022 Report of Independent Registered Public Accounting Firm 2 Balance Sheets as of September 30, 2023 and 2022 3 Statements of Operations and Comprehensive Loss for the years ended September 30, 2023 and 2022 4 Statements of Redeemable Convertible Preferre |
|
| December 28, 2023 |
Mobix Labs, Inc. Code of Business Conduct and Ethics. Exhibit 14.1 Mobix Labs, Inc. Code Of Business Conduct And Ethics Adopted on December 21, 2023 (the “Effective Date”) 1. Purpose Mobix Labs, Inc.. (collectively with its subsidiaries, the “Company”) is committed to promoting high standards of honest and ethical business conduct and compliance with applicable laws, rules and regulations. As part of this commitment, the Company has adopted this Code |
|
| December 28, 2023 |
Exhibit 3.1 CERTIFICATE OF INCORPORATION OF CHAVANT CAPITAL ACQUISITION CORP. I, the undersigned, for the purposes of incorporating and organizing a corporation under the General Corporation Law of the State of Delaware, do hereby execute this certificate of incorporation and do hereby certify as follows: FIRST. The name of the corporation is Chavant Capital Acquisition Corp. (the “Corporation”). |
|
| December 28, 2023 |
Exhibit 4.4 AMENDMENT TO WARRANT AGREEMENT This AMENDMENT TO THE WARRANT AGREEMENT (this “Agreement”) is dated as of December 21, 2023, by and between Chavant Capital Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”). WHEREAS, the Company and the Warrant Agent are part |
|
| December 28, 2023 |
Exhibit 2.5 EXECUTION VERSION AMENDMENT NO. 1 TO THE AGREEMENT AND PLAN OF MERGER This Amendment No. 1 to the Agreement and Plan of Merger (this “Amendment”), dated as of November 28, 2023, to the Agreement and Plan of Merger, dated as of September 26, 2022 (the “Original Agreement”), is by and among (i) Mobix Labs, Inc., a Delaware corporation (“Parent”); (ii) Mobix Merger Sub I, Inc., a Delaware |
|
| December 28, 2023 |
Exhibit 10.5 MOBIX LABS, INC. 2023 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE The purpose of this Plan is to assist Eligible Employees of the Company and its Designated Subsidiaries in acquiring a stock ownership interest in the Company. The Plan consists of two components: (i) the Section 423 Component and (ii) the Non-Section 423 Component. The Section 423 Component is intended to qualify a |
|
| December 28, 2023 |
Exhibit 4.1 NUMBER NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 60743G 100 Mobix Labs, Inc. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CLASS A COMMON STOCK This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.00001 EACH OF THE CLASS A COMMON STOCK OF MOBIX LABS, INC. (THE “COMPANY”) transferable on the books of the Company in perso |
|
| December 28, 2023 |
Letter from BDO USA, P.C. to the U.S. Securities and Exchange Commission, dated December 27, 2023. Exhibit 16.1 Tel: 212-885-8192 Fax: 212-885-8000 www.bdo.com 200 Park Avenue New York, NY 10017 December 27, 2023 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on December 27, 2023, to be filed by our former client, Chavant Capital Acquisition Corp. We agree with th |
|
| December 28, 2023 |
Exhibit 10.4 MOBIX LABS, INC. 2023 EQUITY INCENTIVE PLAN MOBIX LABS, INC. 2023 EQUITY INCENTIVE PLAN 1. Purpose D-1 2. Definitions D-1 3. Administration D-5 4. Shares Subject to Plan D-6 5. Eligibility D-7 6. Specific Terms of Awards D-7 7. Certain Provisions Applicable to Awards D-13 8. Change in Control D-15 9. General Provisions D-16 MOBIX LABS, INC. 2023 EQUITY INCENTIVE PLAN 1. Purpose. |
|
| December 28, 2023 |
Exhibit 4.2 Form of Warrant Certificate [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW MOBIX LABS, INC. Incorporated Under the Laws of the State of Delaware CUSIP 60743G 118 Warrant Certificate This Warrant Certificate certifies that , or registered assigns, is the registered ho |
|
| December 28, 2023 |
Exhibit 99.6 Mobix Labs, Inc. Executive Officer Clawback Policy Approved by the Board of Directors on December 21, 2023 (the “Adoption Date”) I. Purpose This Executive Officer Clawback Policy describes the circumstances under which Covered Persons of Mobix Labs, Inc. and any of its direct or indirect subsidiaries (the “Company”) will be required to repay or return Erroneously-Awarded Compensation |
|
| December 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 21, 2023 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 98-1591717 (State or other jurisdiction of incorporation) (Commission File |
|
| December 28, 2023 |
Exhibit 21.1 Mobix Labs, Inc. List of Subsidiaries Name of Subsidiary State of Jurisdiction of Incorporation Mobix Labs Operations, Inc. Delaware EMI Solutions, LLC California |
|
| December 28, 2023 |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF MOBIX LABS Exhibit 99.5 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF MOBIX LABS Unless otherwise indicated or the context otherwise requires, all references in this Exhibit 99.5 shall have the meanings ascribed to them in the Current Report on Form 8-K (the “Form 8-K”) filed with the Securities and Exchange Commission (the “SEC”) on December 28, 2023 and, if not de |
|
| December 28, 2023 |
Exhibit 10.29 Roth Capital Partners, LLC Craig-Hallum Capital Group LLC 888 San Clemente Drive 222 South Ninth Street, Suite 350 Newport Beach, CA 92660 Minneapolis, MN 55402 December 21, 2023 Chavant Capital Acquisition Corp. 445 Park Avenue, 9th Floor New York, NY 10022 Ladies and Gentlemen: Reference is made to that certain Business Combination Marketing Agreement (the “Agreement”), by and amon |
|
| December 26, 2023 |
Exhibit 10.3 December 20, 2023 Chavant Capital Acquisition Corp. 445 Park Avenue, 9th Floor New York, NY 10022 Re: Subscription Agreement Ladies and Gentlemen: Reference is made to that certain Subscription Agreement (the “Subscription Agreement”), dated as of December 19, 2023, by and among Chavant Capital Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands (t |
|
| December 26, 2023 |
Exhibit 99.1 Mobix Labs, Inc. Closes Business Combination with Chavant Capital Acquisition Corp., Becomes Publicly Traded - Trading to Commence on Nasdaq Under Ticker Symbol “MOBX” on Friday, December 22, 2023 - IRVINE, Calif., December 21, 2023 – Mobix Labs, Inc. (“Mobix Labs” or the “Company”), a fabless semiconductor company developing disruptive next-generation connectivity technologies for 5G |
|
| December 26, 2023 |
Exhibit 10.1 SUBSCRIPTION AGREEMENT Chavant Capital Acquisition Corp. 445 Park Avenue, 9th Floor New York, NY 10022 Ladies and Gentlemen: In connection with the proposed business combination (the “Transaction”) between Chavant Capital Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands (together with any successor thereto, including after the Domestication (as |
|
| December 26, 2023 |
Exhibit 10.8 Execution Version NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY TH |
|
| December 26, 2023 |
Exhibit 10.2 Execution Version NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY TH |
|
| December 26, 2023 |
Exhibit 10.5 Execution Version NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY TH |
|
| December 26, 2023 |
Exhibit 10.7 EXECUTION VERSION NON-REDEMPTION AGREEMENT This NON-REDEMPTION AGREEMENT (this “Agreement”), dated as of December 20, 2023, is made by and among Chavant Capital Acquisition Corp., a Cayman Islands exempted company (the “Company”), Mobix Labs, Inc., a Delaware corporation (“Mobix Labs”), and the Backstop Investor (as defined below). WHEREAS, the Company is a special purpose acquisition |
|
| December 26, 2023 |
Exhibit 10.6 NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATI |
|
| December 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 19, 2023 MOBIX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 001-40621 85-2324794 (State or other jurisdiction of incorporation) (Commission File |
|
| December 26, 2023 |
Exhibit 10.4 FORM OF SUBSCRIPTION AGREEMENT Chavant Capital Acquisition Corp. 445 Park Avenue, 9th Floor New York, NY 10022 Ladies and Gentlemen: In connection with the proposed business combination (the “Transaction”) between Chavant Capital Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands (together with any successor thereto, including after the Domesticat |
|
| December 19, 2023 |
Exhibit 10.2 Execution Version NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY TH |
|
| December 19, 2023 |
Exhibit 10.1 Execution Copy SUBSCRIPTION AGREEMENT Chavant Capital Acquisition Corp. 445 Park Avenue, 9th Floor New York, NY 10022 Ladies and Gentlemen: In connection with the proposed business combination (the “Transaction”) between Chavant Capital Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands (together with any successor thereto, including after the Dom |
|
| December 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 14, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorpor |
|
| December 19, 2023 |
Exhibit 10.3 FORM OF SUBSCRIPTION AGREEMENT Chavant Capital Acquisition Corp. 445 Park Avenue, 9th Floor New York, NY 10022 Ladies and Gentlemen: In connection with the proposed business combination (the “Transaction”) between Chavant Capital Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands (together with any successor thereto, including after the Domesticat |
|
| December 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 14, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorpor |
|
| December 19, 2023 |
Exhibit 10.1 Execution Copy SUBSCRIPTION AGREEMENT Chavant Capital Acquisition Corp. 445 Park Avenue, 9th Floor New York, NY 10022 Ladies and Gentlemen: In connection with the proposed business combination (the “Transaction”) between Chavant Capital Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands (together with any successor thereto, including after the Dom |
|
| December 19, 2023 |
Exhibit 10.2 Execution Version NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT: (I) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO; (II) AN OPINION OF COUNSEL OR OTHER EVIDENCE REASONABLY SATISFACTORY TO THE COMPANY TH |
|
| December 19, 2023 |
Exhibit 10.3 FORM OF SUBSCRIPTION AGREEMENT Chavant Capital Acquisition Corp. 445 Park Avenue, 9th Floor New York, NY 10022 Ladies and Gentlemen: In connection with the proposed business combination (the “Transaction”) between Chavant Capital Acquisition Corp., an exempted company incorporated under the laws of the Cayman Islands (together with any successor thereto, including after the Domesticat |
|
| December 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 18, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorpor |
|
| December 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 18, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorpor |
|
| December 14, 2023 |
Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 14, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorpor |
|
| December 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 14, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorpor |
|
| December 12, 2023 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-271197 PROXY STATEMENT/PROSPECTUS SUPPLEMENT NO. 2 (to Proxy Statement/Prospectus dated November 13, 2023) CHAVANT CAPITAL ACQUISITION CORP. PROSPECTUS FOR 32,406,330 SHARES OF CLASS A COMMON STOCK (INCLUDING SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS) AND 6,000,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK OF CHAVANT CAPITAL |
|
| December 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 12, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorpor |
|
| December 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 12, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorpor |
|
| November 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 26, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorpor |
|
| November 30, 2023 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-271197 PROXY STATEMENT/PROSPECTUS SUPPLEMENT NO. 1 (to Proxy Statement/Prospectus dated November 13, 2023) CHAVANT CAPITAL ACQUISITION CORP. PROSPECTUS FOR 32,406,330 SHARES OF CLASS A COMMON STOCK (INCLUDING SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS) AND 6,000,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK OF CHAVANT CAPITAL |
|
| November 30, 2023 |
Promissory Note, dated November 30, 2023. Exhibit 10.1 THIS PROMISSORY NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO |
|
| November 30, 2023 |
Exhibit 2.1 AMENDMENT NO. 2 TO THE BUSINESS COMBINATION AGREEMENT This AMENDMENT NO. 2 (this “Amendment”), dated as of November 26, 2023, to the Business Combination Agreement, dated as of November 15, 2022, as amended by that certain Amendment No. 1 to the Business Combination Agreement, dated as of April 7, 2023 (as so amended, the “Current Agreement”), is by and among Chavant Capital Acquisitio |
|
| November 30, 2023 |
Calculation of Filing Fee Table. Exhibit 107 Calculation of Filing Fee Table Form S-4 (Form Type) Chavant Capital Acquisition Corp. |
|
| November 30, 2023 |
Promissory Note, dated November 30, 2023. Exhibit 10.1 THIS PROMISSORY NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO |
|
| November 30, 2023 |
Supplemental Disclosures to the Proxy Statement/Prospectus Exhibit 99.1 Supplemental Disclosures to the Proxy Statement/Prospectus The following disclosures supplement the disclosures contained in the Proxy Statement/Prospectus and should be read in conjunction with the disclosures contained in the Proxy Statement/Prospectus, which in turn should be read in its entirety. All page references are to the Proxy Statement/Prospectus, and terms used below, unle |
|
| November 30, 2023 |
As filed with the Securities and Exchange Commission on November 30, 2023 As filed with the Securities and Exchange Commission on November 30, 2023 Registration No. |
|
| November 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 26, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorpor |
|
| November 30, 2023 |
Exhibit 2.1 AMENDMENT NO. 2 TO THE BUSINESS COMBINATION AGREEMENT This AMENDMENT NO. 2 (this “Amendment”), dated as of November 26, 2023, to the Business Combination Agreement, dated as of November 15, 2022, as amended by that certain Amendment No. 1 to the Business Combination Agreement, dated as of April 7, 2023 (as so amended, the “Current Agreement”), is by and among Chavant Capital Acquisitio |
|
| November 30, 2023 |
Supplemental Disclosures to the Proxy Statement/Prospectus Exhibit 99.1 Supplemental Disclosures to the Proxy Statement/Prospectus The following disclosures supplement the disclosures contained in the Proxy Statement/Prospectus and should be read in conjunction with the disclosures contained in the Proxy Statement/Prospectus, which in turn should be read in its entirety. All page references are to the Proxy Statement/Prospectus, and terms used below, unle |
|
| November 21, 2023 |
Filed by Chavant Capital Acquisition Corp. Pursuant to Rule 425 under the Securities Act of 1933 Subject Company: Chavant Capital Acquisition Corp. Commission File No. 333-271197 Date: November 21, 2023 Mobix Labs, Inc. and Chavant Capital Acquisition Corp. Announce Effectiveness of Registration Statement on Form S-4 Extraordinary General Meeting of Chavant Shareholders to Approve Proposed Busines |
|
| November 15, 2023 |
TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration No. 333-271197 PROXY STATEMENT FOR THE EXTRAORDINARY GENERAL MEETING OF CHAVANT CAPITAL ACQUISITION CORP. PROSPECTUS FOR 27,005,275 SHARES OF CLASS A COMMON STOCK (INCLUDING SHARES OF CLASS A COMMON STOCK UNDERLYING WARRANTS) AND 6,000,000 WARRANTS TO PURCHASE SHARES OF CLASS A COMMON STOCK OF CHAVANT CAPITAL ACQUISITION CORP. (AFTE |
|
| November 14, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Chavant Capital Acquisition Corp. (Exact name of regist |
|
| November 13, 2023 |
As filed with the Securities and Exchange Commission on November 13, 2023 Table of Contents As filed with the Securities and Exchange Commission on November 13, 2023 Registration No. |
|
| November 13, 2023 |
Chavant Capital Acquisition Corp. 445 Park Avenue, 9th Floor New York, NY 10022 Chavant Capital Acquisition Corp. 445 Park Avenue, 9th Floor New York, NY 10022 November 13, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3561 Attention: Beverly Singleton, Jean Yu, Jenny O’Shanick, Asia Timmons-Pierce Re: Acceleration Request for Chavant Capital Acquisition Corp. Registration Statement on |
|
| November 13, 2023 |
November 13, 2023 Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D. |
|
| November 13, 2023 |
November 13, 2023 Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D. |
|
| November 13, 2023 |
Calculation of Filing Fee Table. Exhibit 107 Calculation of Filing Fee Table Form S-4 (Form Type) Chavant Capital Acquisition Corp. |
|
| November 3, 2023 |
Exhibit 10.15 EXECUTION VERSION AMENDED AND RESTATED EXECUTIVE EMPLOYMENT TERM SHEET This binding amended and restated executive employment term sheet (the “Amended Employment Term Sheet”) amends and restates, in its entirety, the terms of that certain Executive Employment Term Sheet, dated November 15, 2022 (the “Existing Term Sheet”), by and between Fabrizio Battaglia (the “Executive”) and Mobix |
|
| November 3, 2023 |
Exhibit 10.14 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), is effective as of September 5, 2020, (the “Effective Date”) is made and entered by and between Mobix Labs, Inc., a Delaware corporation (the “Company”), and Fabrizio Battaglia (the “Executive”). WITNESSETH: WHEREAS, the Executive has been appointed as the Company’s Chief Execu |
|
| November 3, 2023 |
Exhibit 10.17 EXECUTION VERSION AMENDED AND RESTATED EXECUTIVE EMPLOYMENT TERM SHEET This binding amended and restated executive employment term sheet (the “Amended Employment Term Sheet”) amends and restates, in its entirety, the terms of that certain Executive Employment Term Sheet, dated November 15, 2022 (the “Existing Term Sheet”), by and between Keyvan Samini (the “Executive”) and Mobix Labs |
|
| November 3, 2023 |
As filed with the Securities and Exchange Commission on November 2, 2023 Table of Contents As filed with the Securities and Exchange Commission on November 2, 2023 Registration No. |
|
| November 3, 2023 |
Exhibit 10.16 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”), is effective as of September 5, 2020, (the “Effective Date”) is made and entered by and between Mobix Labs, Inc., a Delaware corporation (the “Company”), and Keyvan Samini (the “Executive”). WITNESSETH: WHEREAS, the Executive has been appointed as the Company’s Chief Financial |
|
| November 3, 2023 |
Exhibit 4.5 FORM OF AMENDMENT TO WARRANT AGREEMENT This AMENDMENT TO THE WARRANT AGREEMENT (this “Agreement”) is dated as of [], 2023, by and between Chavant Capital Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”). WHEREAS, the Company and the Warrant Agent are parti |
|
| November 3, 2023 |
Calculation of Filing Fee Table. Exhibit 107 Calculation of Filing Fee Table Form S-4 (Form Type) Chavant Capital Acquisition Corp. |
|
| November 2, 2023 |
November 2, 2023 Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D. |
|
| October 24, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 18, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorpora |
|
| September 26, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 20, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorpo |
|
| August 30, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 24, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorporat |
|
| August 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 18, 2023 CHAVANT CAPITAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Cayman Islands 001-40621 98-1591717 (State or other jurisdiction of incorporat |
|
| August 18, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Chavant Capital Acquisition Corp. (Exact name of registrant |
|
| August 18, 2023 |
Amended and Restated Memorandum and Articles of Association. Exhibit 3.1 Registrar of Companies Government Administration Building 133 Elgin Avenue George Town Grand Cayman Chavant Capital Acquisition Corp. (ROC # 373237) (the “Company”) TAKE NOTICE that by minutes of an extraordinary general meeting of the Company dated 18 July 2023, the following special resolutions were passed: 1. “RESOLVED, as a special resolution that the Amended and Restated Memorandu |
|
| August 14, 2023 |
PART I — REGISTRANT INFORMATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION SEC FILE NUMBER WASHINGTON, DC 20549 001-40621 CUSIP NUMBER FORM 12b-25 G2058L103 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-CEN ¨ Form N-CSR For Period Ended: June 30, 2023 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| August 11, 2023 |
Exhibit 3.1 Registrar of Companies Government Administration Building 133 Elgin Avenue George Town Grand Cayman Chavant Capital Acquisition Corp. (ROC # 373237) (the “Company”) TAKE NOTICE that by minutes of an extraordinary general meeting of the Company dated 18 July 2023, the following special resolutions were passed: 1. “RESOLVED, as a special resolution that the Amended and Restated Memorandu |
|
| August 11, 2023 |
Calculation of Filing Fee Table. Exhibit 107 Calculation of Filing Fee Table Form S-4 (Form Type) Chavant Capital Acquisition Corp. |
|
| August 11, 2023 |
August 11, 2023 Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D. |
|
| August 11, 2023 |
As filed with the Securities and Exchange Commission on August 11, 2023 Table of Contents As filed with the Securities and Exchange Commission on August 11, 2023 Registration No. |
